New Potomac Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $467K | Sell |
3,210
-150
| -4% | -$21.8K | 0.24% | 68 |
|
|
2024
Q2 | $461K | Sell |
3,360
-100
| -3% | -$13.7K | 0.25% | 70 |
|
|
2024
Q1 | $475K | Hold |
3,460
| – | – | 0.26% | 68 |
|
|
2023
Q4 | $470K | Hold |
3,460
| – | – | 0.28% | 70 |
|
|
2023
Q3 | $423K | Sell |
3,460
-60
| -2% | -$7.34K | 0.29% | 65 |
|
|
2023
Q2 | $447K | Sell |
3,520
-200
| -5% | -$25.4K | 0.29% | 63 |
|
|
2023
Q1 | $480K | Hold |
3,720
| – | – | 0.33% | 61 |
|
|
2022
Q4 | $488K | Buy |
3,720
+40
| +1% | +$5.25K | 0.36% | 59 |
|
|
2022
Q3 | $430K | Sell |
3,680
-29
| -0.8% | -$3.39K | 0.36% | 54 |
|
|
2022
Q2 | $436K | Sell |
3,709
-100
| -3% | -$11.8K | 0.35% | 53 |
|
|
2022
Q1 | $496K | Hold |
3,809
| – | – | 0.35% | 51 |
|
|
2021
Q4 | $581K | Hold |
3,809
| – | – | 0.38% | 50 |
|
|
2021
Q3 | $616K | Sell |
3,809
-325
| -8% | -$52.6K | 0.43% | 49 |
|
|
2021
Q2 | $677K | Hold |
4,134
| – | – | 0.46% | 49 |
|
|
2021
Q1 | $622K | Sell |
4,134
-1
| -0% | -$150 | 0.46% | 52 |
|
|
2020
Q4 | $626K | Sell |
4,135
-385
| -9% | -$58.3K | 0.45% | 52 |
|
|
2020
Q3 | $612K | Sell |
4,520
-60
| -1% | -$8.12K | 0.49% | 50 |
|
|
2020
Q2 | $626K | Hold |
4,580
| – | – | 0.56% | 49 |
|
|
2020
Q1 | $493K | Sell |
4,580
-1,555
| -25% | -$167K | 0.54% | 48 |
|
|
2019
Q4 | $739K | Sell |
6,135
-1,240
| -17% | -$149K | 0.69% | 46 |
|
|
2019
Q3 | $734K | Sell |
7,375
-190
| -3% | -$18.9K | 0.73% | 48 |
|
|
2019
Q2 | $825K | Sell |
7,565
-490
| -6% | -$53.4K | 0.84% | 45 |
|
|
2019
Q1 | $901K | Sell |
8,055
-290
| -3% | -$32.4K | 0.91% | 44 |
|
|
2018
Q4 | $805K | Buy |
8,345
+380
| +5% | +$36.7K | 0.87% | 43 |
|
|
2018
Q3 | $971K | Sell |
7,965
-200
| -2% | -$24.4K | 0.9% | 43 |
|
|
2018
Q2 | $897K | Sell |
8,165
-173
| -2% | -$19K | 0.87% | 42 |
|
|
2018
Q1 | $890K | Sell |
8,338
-115
| -1% | -$12.3K | 0.87% | 43 |
|
|
2017
Q4 | $903K | Buy |
+8,453
| New | +$903K | 0.86% | 44 |
|